PubRank

R Elashoff

Author PubWeight™ 56.55‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Weight-supported treadmill vs over-ground training for walking after acute incomplete SCI. Neurology 2006 6.66
2 Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 1999 3.56
3 An association between renal cell carcinoma and lymphoid malignancies. A case series of eight patients. Cancer 1996 3.12
4 Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res 2001 2.53
5 Bevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experience. Neurology 2009 2.41
6 Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 1993 2.38
7 The evolution of walking-related outcomes over the first 12 weeks of rehabilitation for incomplete traumatic spinal cord injury: the multicenter randomized Spinal Cord Injury Locomotor Trial. Neurorehabil Neural Repair 2006 1.94
8 A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures. Arch Gen Psychiatry 1990 1.71
9 A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbance. Arch Gen Psychiatry 1990 1.66
10 Montelukast improves regional air-trapping due to small airways obstruction in asthma. Eur Respir J 2006 1.61
11 Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine. Ann Surg 1992 1.50
12 Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence. Cancer Res 2000 1.38
13 Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma. Ann Surg Oncol 1999 1.27
14 Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol 1999 1.22
15 Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein. Eur J Clin Nutr 2005 1.21
16 Implementation of a primary care physician network obesity management program. Obes Res 2001 1.11
17 Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire? Diabetologia 2009 1.10
18 A computer-aided diagnosis system for quantitative scoring of extent of lung fibrosis in scleroderma patients. Clin Exp Rheumatol 2010 1.09
19 Shed tumor gangliosides and progression of human neuroblastoma. Blood 1990 1.05
20 Liquid meal replacements and glycemic control in obese type 2 diabetes patients. Obes Res 2001 1.04
21 Individualized prognosis for melanoma patients. Hum Pathol 2000 1.04
22 Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial. Ann Intern Med 1986 1.03
23 Multiple markers for lung cancer diagnosis: validation of models for advanced lung cancer. J Natl Cancer Inst 1986 1.02
24 Treatment of acute myelogenous leukemia. A prospective controlled trial of bone marrow transplantation versus consolidation chemotherapy. Ann Intern Med 1985 1.00
25 Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction. Br J Cancer 2011 0.99
26 Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran. Cancer 1998 0.98
27 Feasibility of a low-fat/high-fiber diet intervention with soy supplementation in prostate cancer patients after prostatectomy. Eur J Clin Nutr 2007 0.90
28 Adjuvant dietary fat intake reduction in postmenopausal breast cancer patient management. The Women's Intervention Nutrition Study (WINS). Breast Cancer Res Treat 1992 0.89
29 Is the survival of melanoma patients receiving polyvalent melanoma cell vaccine linked to the human leukocyte antigen phenotype of patients? J Clin Oncol 1998 0.87
30 Significance of workplace smoking. Am J Public Health 1998 0.84
31 Multiple markers for lung cancer diagnosis: validation of models for localized lung cancer. J Natl Cancer Inst 1988 0.83
32 Polyvalent melanoma vaccine improves survival of patients with metastatic melanoma. Ann N Y Acad Sci 1993 0.81
33 Analysis of weight loss outcomes using VLCD in black and white overweight and obese women with and without metabolic syndrome. Int J Obes (Lond) 2005 0.81
34 A breast cancer Nutrition Adjuvant Study (NAS): protocol design and initial patient adherence. Breast Cancer Res Treat 1987 0.80
35 Prolonged survival in acute myelogenous leukaemia without maintenance chemotherapy. Lancet 1984 0.80
36 Staphylococcus via an interaction with the ELR+ CXC chemokine ENA-78 is associated with BOS. Am J Transplant 2015 0.79
37 Hydrazine sulfate influence on nutritional status and survival in non-small-cell lung cancer. J Clin Oncol 1990 0.78
38 Comparison of speeds used for the 15.2-meter and 6-minute walks over the year after an incomplete spinal cord injury: the SCILT Trial. Neurorehabil Neural Repair 2007 0.78
39 Evoked potential analysis by complex demodulation. Electroencephalogr Clin Neurophysiol 1972 0.77
40 Modulation of serum and breast ductal fluid lipids by a very-low-fat, high-fiber diet in premenopausal women. J Natl Cancer Inst 1994 0.77
41 Insulin-leptin-visceral fat relation during weight loss. Pancreas 2001 0.77
42 [The evaluation of controlled trachoma chimiotherapy trial]. Rev Int Trach 1972 0.75
43 Unpublished Data Summaries and the design and conduct of clinical trials. The Nutrition Adjuvant Study experience and commentary. Control Clin Trials 1989 0.75
44 The evaluation of controlled trachoma chemotherapy trials. Rev Int Trach 1968 0.75
45 Optimal design of clinical outcome studies in nutrition and cancer: future directions. JPEN J Parenter Enteral Nutr 1993 0.75
46 Current status: evaluation of dietary fat reduction as secondary breast cancer prevention. The Nutrition Adjuvant Study. Prog Clin Biol Res 1990 0.75
47 Improved survival for patients with AIDS-related Kaposi's sarcoma. J Clin Oncol 1994 0.75
48 Progress report on the prophylactic use of oral hypoglycemic drugs in asymptomatic diabetes: neurovascular studies. Adv Metab Disord 1973 0.75
49 Mitoxantrone use in breast cancer patients with elevated bilirubin. Breast Cancer Res Treat 1989 0.75